Abstract
The landscape of neonatal follow up is starting to shift. While there is continued emphasis on the traditional outcomes studied, including cerebral palsy, vision/hearing impairment, and cognitive impairment, there is a shift in focus to those outcomes which are much more prevalent and collectively can contribute to significant morbidity. The purpose of this review is to explore the outcomes of the preterm survivor, in the context of the principles of neurodevelopment. Approaching these outcomes from a developmental perspective provides insight into the challenges in early identification and management of these highly prevalent outcomes. In addition, we will explore the underlying brain injury associated with the preterm infant, particularly as it relates to the high prevalence low severity outcomes. We will also review the impact of this pattern in terms of clinical presentation and academic performance. Finally, we will look at the limitations within the medical system and community that potentially exacerbate the difficulties of the preterm survivor.
Keywords: Behavioral phenotype, brain injury, neurodevelopment, outcomes, prematurity, school readiness
Current Pediatric Reviews
Title:The Perfect Storm: The High Prevalence Low Severity Outcomes of the Preterm Survivors
Volume: 8 Issue: 2
Author(s): Paige Terrien Church, Maureen Luther and Elizabeth Asztalos
Affiliation:
Keywords: Behavioral phenotype, brain injury, neurodevelopment, outcomes, prematurity, school readiness
Abstract: The landscape of neonatal follow up is starting to shift. While there is continued emphasis on the traditional outcomes studied, including cerebral palsy, vision/hearing impairment, and cognitive impairment, there is a shift in focus to those outcomes which are much more prevalent and collectively can contribute to significant morbidity. The purpose of this review is to explore the outcomes of the preterm survivor, in the context of the principles of neurodevelopment. Approaching these outcomes from a developmental perspective provides insight into the challenges in early identification and management of these highly prevalent outcomes. In addition, we will explore the underlying brain injury associated with the preterm infant, particularly as it relates to the high prevalence low severity outcomes. We will also review the impact of this pattern in terms of clinical presentation and academic performance. Finally, we will look at the limitations within the medical system and community that potentially exacerbate the difficulties of the preterm survivor.
Export Options
About this article
Cite this article as:
Terrien Church Paige, Luther Maureen and Asztalos Elizabeth, The Perfect Storm: The High Prevalence Low Severity Outcomes of the Preterm Survivors, Current Pediatric Reviews 2012; 8 (2) . https://dx.doi.org/10.2174/157339612800681325
DOI https://dx.doi.org/10.2174/157339612800681325 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
“Vascular Incontinence” and Normal-Pressure Hydrocephalus: Two Commonsources of Elderly Incontinence with Brain Etiologies
Current Drug Therapy Perspectives On Membrane-associated Progesterone Receptors As Prospective Therapeutic Targets
Current Drug Targets Inhibition of Brain Phospholipase A2 by Antimalarial Drugs: Implications for Neuroprotection in Neurological Disorders
Medicinal Chemistry Reviews - Online (Discontinued) Axotomy Leads to Reduced Calcium Increase and Earlier Termination of CCL2 Release in Spinal Motoneurons with Upregulated Parvalbumin Followed by Decreased Neighboring Microglial Activation
CNS & Neurological Disorders - Drug Targets The Protective Effects of Natural Products on Blood-Brain Barrier Breakdown
Current Medicinal Chemistry Chronic Stress and Alzheimers Disease-Like Pathogenesis in a Rat Model: Prevention by Nicotine
Current Neuropharmacology Stem Cell Therapies for the Lysosomal Storage Diseases – the Quintessential Neurodegenerative Diseases
Current Stem Cell Research & Therapy Remyelination in Multiple Sclerosis: The Therapeutic Potential of Neural and Mesenchymal Stem/Progenitor Cells
Current Signal Transduction Therapy Update in Pharmacological Management of Coronary No-Reflow Phenomenon
Cardiovascular & Hematological Agents in Medicinal Chemistry De Novo and Molecular Target-Independent Discovery of Orally Bioavailable Lead Compounds for Neurological Disorders
Current Alzheimer Research Amyloid Beta Peptide, 4-Hydroxynonenal and Apoptosis
Current Alzheimer Research Peripheral Opioid Analgesia
Current Pharmaceutical Biotechnology Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases
Current Drug Targets Traumatic Brain Injury Altered Normal Brain Signaling Pathways: Implications for Novel Therapeutics Approaches
Current Neuropharmacology Quantitative Ultrasound in Diagnosis of Metabolic Bone Diseases
Current Medical Imaging Strategies to Improve Bioavailability and <i>In Vivo</i> Efficacy of the Endogenous Opioid Peptides Endomorphin-1 and Endomorphin-2
Current Topics in Medicinal Chemistry Shut-Down of Translation, a Global Neuronal Stress Response:Mechanisms and Pathological Relevance
Current Pharmaceutical Design Peptidyl Arginine Deiminases and Neurodegenerative Diseases
Current Medicinal Chemistry Combinational Approaches Targeting Neurodegeneration, Oxidative Stress, and Inflammation in the Treatment of Diabetic Retinopathy
Current Drug Targets Pharmacological Strategies that Affect HIF-1 in the Ischemic Brain: Focus on Hydroxylases Activity and Protein Kinase Pathways
Current Signal Transduction Therapy